Buy 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride CAS 93413-77-5: Leading Pharmaceutical Intermediate Manufacturer & Supplier

Source high-quality 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride (CAS 93413-77-5) for your pharmaceutical synthesis needs. As a leading manufacturer and supplier in China, we offer competitive pricing and reliable global supply.

Get a Quote & Sample

Advantages of Sourcing from Us

Exceptional Purity for Pharmaceutical Applications

Our 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride meets rigorous purity specifications, making it ideal for sensitive pharmaceutical synthesis and research. We ensure that every order aligns with your critical quality requirements.

Consistent Supply Chain Management

We understand the importance of uninterrupted supply. As a dedicated supplier of pharmaceutical intermediates, we maintain robust inventory and production capabilities to meet your ongoing demands for CAS 93413-77-5.

Expert Support and Technical Data

Leverage our expertise as a leading manufacturer. We provide comprehensive technical documentation, including COAs and MSDS, to support your research and development processes for this Venlafaxine intermediate.

Key Applications and Research Areas

Pharmaceutical Synthesis

Utilize 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride as a vital intermediate in the synthesis of active pharmaceutical ingredients (APIs), particularly for neurological and psychiatric medications.

Drug Metabolism Studies

This compound serves as a key metabolite of Venlafaxine, making it indispensable for researchers studying drug metabolism, pharmacokinetics, and the development of novel therapeutic agents for CNS disorders.

Neurochemical Research

Explore the mechanisms of action of monoamine reuptake inhibitors. This chemical is essential for advancing neurochemistry research and identifying new treatment pathways.

Custom Synthesis Projects

We support custom synthesis projects, offering this intermediate as a building block for novel compound development in pharmaceutical R&D, ensuring quality and scalability.